Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.43B |
| 3 |
Boeing
BA
|
+$283M |
| 4 |
CrowdStrike
CRWD
|
+$251M |
| 5 |
Coinbase
COIN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$845M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$837M |
| 3 |
Broadcom
AVGO
|
+$691M |
| 4 |
NVIDIA
NVDA
|
+$662M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$660M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.75% |
| 2 | Technology | 1.85% |
| 3 | Consumer Discretionary | 1.02% |
| 4 | Financials | 0.76% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11376
CALL
Intellicheck
IDN
$57.6M
| $44.3K | ﹤0.01% |
20,400
+4,900
| +32% | +$12.8K |
|
11377
PUT
Expensify
EXFY
$233M
| $43.9K | ﹤0.01% |
+22,400
| New | +$46.5K |
|
11378
CALL
Puma Biotechnology
PBYI
$477M
| $43.9K | ﹤0.01% |
17,200
-53,000
| -75% | -$160K |
|
11379
PUT
Pyxis Oncology
PYXS
$277M
| $43.7K | ﹤0.01% |
+11,900
| New | +$41.6K |
|
11380
Super League Enterprise
SLE
$177M
| $43.7K | ﹤0.01% |
+146
| New | +$73.7K |
|
11381
PodcastOne
PODC
$82M
| $43.6K | ﹤0.01% |
+28,505
| New | +$43.4K |
|
11382
Quantum Computing Inc
QUBT
$1.96B
| $43.3K | ﹤0.01% |
66,341
+42,416
| +177% | +$27.1K |
|
|
AMPS
11383
PUT
DELISTED
Altus Power
AMPS
| $43.2K | ﹤0.01% |
13,600
-11,500
| -46% | -$41K |
|
11384
Stem
STEM
$54.9M
| $43.2K | ﹤0.01% |
6,200
-17,765
| -74% | -$280K |
|
11385
PUT
Galectin Therapeutics
GALT
$418M
| $43.2K | ﹤0.01% |
+15,700
| New | +$38.6K |
|
11386
Codexis
CDXS
$182M
| $43.1K | ﹤0.01% |
13,987
-12,961
| -48% | -$40.1K |
|
|
TRUE
11387
DELISTED
TrueCar
TRUE
| $43K | ﹤0.01% |
12,471
-18,348
| -60% | -$58.9K |
|
|
LVTX
11388
CALL
DELISTED
LAVA Therapeutics
LVTX
| $43K | ﹤0.01% |
25,900
-47,200
| -65% | -$86.4K |
|
|
ALUR
11389
CALL
DELISTED
Allurion Technologies
ALUR
| $42.9K | ﹤0.01% |
+2,812
| New | +$54.9K |
|
11390
Actinium Pharmaceuticals
ATNM
$31.4M
| $42.3K | ﹤0.01% |
22,488
-18,221
| -45% | -$72K |
|
11391
PUT
GSI Technology
GSIT
$228M
| $42.1K | ﹤0.01% |
13,800
+3,800
| +38% | +$10.4K |
|
|
OGI
11392
PUT
Organigram Holdings
OGI
$173M
| $42K | ﹤0.01% |
23,200
-39,100
| -63% | -$68.1K |
|
|
CUTR
11393
PUT
DELISTED
Cutera, Inc.
CUTR
| $41.9K | ﹤0.01% |
53,100
-99,700
| -65% | -$103K |
|
|
GRTS
11394
PUT
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $41.9K | ﹤0.01% |
72,300
+3,400
| +5% | +$1.91K |
|
|
DAO
11395
PUT
Youdao
DAO
$1.98B
| $41.9K | ﹤0.01% |
10,100
-200
| -2% | -$686 |
|
11396
Ultrapar
UGP
$6.84B
| $41.9K | ﹤0.01% |
10,791
-6,794
| -39% | -$28K |
|
11397
Kiora Pharmaceuticals
KPRX
$11.8M
| $41.7K | ﹤0.01% |
+11,382
| New | +$44.4K |
|
11398
PUT
Traeger
COOK
$156M
| $41.6K | ﹤0.01% |
226
| – | – |
|
11399
CALL
Red Cat Holdings
RCAT
$1.42B
| $41.1K | ﹤0.01% |
16,200
-5,400
| -25% | -$12.9K |
|
11400
Verrica Pharmaceuticals
VRCA
$87.1M
| $40.8K | ﹤0.01% |
2,816
+831
| +42% | +$37.4K |
|
Similar funds
Jeff Yass's Q3 2024 Portfolio in Review
As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
- Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
- Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
- Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
- Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
- Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.
Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.